ARCHIVE

• Tanabe Licenses Bepotastine to Senju as Eye Drop
  July 30, 2001

• Differences in Prices of Catheters in Japan, Abroad Highlighted: JSIC Meeting
  July 30, 2001

• Makers Accelerating Business Restructuring
  July 30, 2001

• WORLD NEWS IN BRIEF
  July 30, 2001

• Drug Dispensing Cost Outstrips Dental Care Cost
  July 30, 2001

• JST Select 10 Research Themes to Support in FY2001
  July 30, 2001

• 5 Products Including NovoRapid, Isuhuman, Flutide Recommended for Approval
  July 30, 2001

• Glivec Highly Effective against CML: Novartis Seminar
  July 30, 2001

• Stomach Cancer to Be Approved as New Indication for Taxol
  July 30, 2001

• Risperdal Effective for Positive Symptoms of Schizophrenia: Dr Grogg of Janssen
  July 30, 2001

• World Anti-cancer Market to Expand to \3 Trillion in 2005: Consultant
  July 30, 2001

• Int'l Study on Rofecoxib in OA Patients Begins: Banyu, Merck
  July 30, 2001

• Kyowa Hakko Enters PI in Europe for Anti-asthma KW-4490
  July 30, 2001

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
  July 23, 2001

• Taisho, GSK to Jointly Develop Smoking Cessation Aid
  July 23, 2001

• Enhancing Competitiveness of Japanese Makers Discussed: OPIR Report
  July 23, 2001

• Concomitant HD, CAPD Effective for Chronic Renal Failure: Terumo Seminar
  July 23, 2001

• Reports of Medical Device Malfunctions Increasing
  July 23, 2001

• REGULATORY NEWS IN BRIEF
  July 23, 2001

• Aventis Obtains World Rights to New Cancer Agent from Ajinomoto
  July 23, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 740
• 741
• 742
• 743
• 744
• 745
• 746
• 747
• 748
• …
• Next ›
• 最終 »